Stroke Statistics in Korea: Part I. Epidemiology and Risk Factors: A Report from the Korean Stroke Society and Clinical Research Center for Stroke

The aim of the Part I of Stroke Statistics in Korea is to summarize nationally representative data of the epidemiology and risk factors of stroke in a single document. Every year, approximately 105,000 people experience a new or recurrent stroke and more than 26,000 die of stroke, which indicates that every 5 minutes stroke attacks someone and every 20 minutes stroke kills someone in Korea. Stroke accounts for roughly 1 of every 10 deaths. The estimated stroke prevalence is about 795,000 in people aged ≥30 years. The nationwide total cost for stroke care was 3,737 billion Korean won (US$3.3 billion) in 2005. Fortunately, the annual stroke mortality rate decreased substantially by 28.3% during the first decade of the 21th century (53.2/100,000 in 2010). Among OECD countries, Korea had the lowest in-hospital 30-day case-fatality rate for ischemic stroke and ranked third lowest for hemorrhagic stroke in 2009. The proportion of ischemic stroke has steadily increased and accounted for 76% of all strokes in 2009. According to hospital registry studies, the 90-day mortality rate was 3-7% for ischemic stroke and 17% for intracerebral hemorrhage. For risk factors, among Korean adults ≥30 years of age, one in 3-4 has hypertension, one in 10 diabetes, and one in 7 hypercholesterolemia. One in 3 Korean adults ≥19 years of age is obese. Over the last 10 years, the prevalence of hypertension slightly decreased, but the prevalence of diabetes, hypercholesterolemia, and obesity increased. Smoking prevalence in men has decreased, but is still as high as 48%. This report could be a valuable resource for establishing health care policy and guiding future research directions.

[1]  J. Barendregt,et al.  Global burden of disease , 1997, The Lancet.

[2]  K. Reynolds,et al.  Global burden of hypertension: analysis of worldwide data , 2005, The Lancet.

[3]  David Lee Gordon,et al.  Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.

[4]  Sc Prospective,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002 .

[5]  P. Duncan,et al.  Measurement of Motor Recovery After Stroke: Outcome Assessment and Sample Size Requirements , 1992, Stroke.

[6]  Thomas Lumley,et al.  Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. , 2003, JAMA.

[7]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[8]  KjellAsplund,et al.  Country Comparisons of Human Stroke Research Since 2001 , 2012 .

[9]  W. Cullen,et al.  Research confuses me: what is the difference between case-control and cohort studies in quantitative research? , 2013, Irish medical journal.

[10]  Differences of Mortality and Dependence Between Stroke Unit and General Ward Care in Acute Ischemic Stroke Patients. , 2009 .

[11]  C. Nam,et al.  [Socioeconomic costs of stroke in Korea: estimated from the Korea national health insurance claims database]. , 2009, Journal of preventive medicine and public health = Yebang Uihakhoe chi.

[12]  L. Appel,et al.  Smoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol: the Korea Medical Insurance Corporation Study. , 1999, JAMA.

[13]  S. Nikfar,et al.  Organization for Economic Cooperation and Development (OECD) , 2014 .

[14]  D. Liew,et al.  Estimating the lifetime economic burden of stroke according to the age of onset in South Korea: a cost of illness study , 2011, BMC public health.

[15]  S. Jee,et al.  Smoking and atherosclerotic cardiovascular disease in women with lower levels of serum cholesterol. , 2007, Atherosclerosis.

[16]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association. , 2012, Circulation.

[17]  K. Yu,et al.  Impact of neurological and medical complications on 3‐month outcomes in acute ischaemic stroke , 2008, European journal of neurology.

[18]  Kyu-Hong Kim Predictors of 30-day mortality and 90-day functional recovery after primary intracerebral hemorrhage : hospital based multivariate analysis in 585 patients. , 2009, Journal of Korean Neurosurgical Society.

[19]  O. Persson,et al.  Country Comparisons of Human Stroke Research Since 2001: A Bibliometric Study , 2012, Stroke.

[20]  大韓民國統計廳,et al.  死亡原因統計年報 : 人口動態申告에 의한 集計 = Annual report on the cause of death statistics : based on vital registration , 1991 .

[21]  Jinkwon Kim,et al.  Different prognostic value of white blood cell subtypes in patients with acute cerebral infarction. , 2012, Atherosclerosis.

[22]  Anthony S. Kim,et al.  Global Variation in the Relative Burden of Stroke and Ischemic Heart Disease , 2011, Circulation.

[23]  D. Kang,et al.  Burden of Ischemic Stroke in Korea: Analysis of Disability-Adjusted Life Years Lost , 2011, Journal of clinical neurology.

[24]  Scott E Kasner,et al.  Clinical interpretation and use of stroke scales , 2006, The Lancet Neurology.

[25]  S Claiborne Johnston,et al.  Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling , 2009, The Lancet Neurology.

[26]  Werner Hacke,et al.  Contemporary Outcome Measures in Acute Stroke Research: Choice of Primary Outcome Measure , 2012, Stroke.

[27]  R. Holman,et al.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study , 2000, BMJ : British Medical Journal.

[28]  Keun-Hwa Jung,et al.  Secular Trends in Ischemic Stroke Characteristics in a Rapidly Developed Country: Results From the Korean Stroke Registry Study (Secular Trends in Korean Stroke) , 2012, Circulation. Cardiovascular quality and outcomes.

[29]  P. Amarenco,et al.  Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention , 2009, The Lancet Neurology.

[30]  C. Oh,et al.  Current Status of Stroke Management in Korea , 2002 .

[31]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.